Bolt Biotherapeutics, Inc., incorporated in Delaware on January 22, 2015 as Bolt Therapeutics, Inc., is headquartered in Redwood City, California. The company changed its name to Bolt Biotherapeutics, Inc., on July 29, 2015. The company is a clinical-stage immuno-oncology company that develops tumor-targeted therapies utilizing the innate and adaptive immune systems.
